The role od defensins in virus-induced asthma

Current Allergy and Asthma Reports

Volumn 6, Issue 1, 2006, Pages 81-85

  Proud, David ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENSIN; POLYPEPTIDE ANTIBIOTIC AGENT;

AIRWAY; ANTIVIRAL ACTIVITY; ASTHMA; CELL ACTIVITY; CELL TYPE; DENDRITIC CELL; DISEASE EXACERBATION; EPITHELIUM CELL; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; MAST CELL; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; REVIEW; VIRUS; VIRUS INFECTION; ANIMAL; CELLULAR IMMUNITY; GENETICS; IMMUNOLOGY; INFANT; INFLAMMATION; LUNG DISEASE; NEWBORN; PATHOPHYSIOLOGY; VIROLOGY;

ANIMALS; ASTHMA; DEFENSINS; HUMANS; IMMUNITY, CELLULAR; INFANT; INFANT, NEWBORN; INFLAMMATION; LUNG DISEASES; VIRUS DISEASES;

EID: 33645379318     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-006-0015-6     Document Type: Review

References (50)

1. Gern JE: Viral respiratory infection and the link to asthma. Pediatr Infect Dis J 2004, 23:S78-S86.
2. Schneider JJ, Unholzer A, Schaller M, et al.: Human defensins. J Mol Med 2005, 83:587-595.
3. Cole AM, Hong T, Boo LM, et al.: Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc Natl Acad Sci (USA) 2002, 99:1813-1818.
4. Schutte BC, McCray PBJ: Beta-defensins in lung host defense. Annu Rev Physiol 2002, 64:709-748.
5. Jia HP, Schutte BC, Schudy A, et al.: Discovery of new human beta-defensins using a genomics-based approach. Gene 2001, 263:211-218.
6. Ganz T, Weiss J: Antimicrobial peptides of phagocytes and epithelia. Semin Hematol 1997, 34:343-354.
7. Garcia J-RC, Krause A, Schulz S, et al.: Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 2001, 15:1819-1821.
8. Ober C, Tsalenko A, Parry R, Cox NJ: A second-generation genomewide screen for asthma-susceptibility alleles in a founder population. Am J Hum Genet 2000, 67:1154-1162.
9. Hsu FC, Liang KY, Beaty TH: Multipoint linkage disequilibrium mapping approach: incorporating evidence of linkage and linkage disequilibrium from unlinked region. Genet Epidemiol 2003, 25:1-13.
10. Levy H, Raby BA, Lake S, et al.: Association of defensin beta-1 gene polymorphisms with asthma. J Allergy Clin Immunol 2005, 115:252-258.
11. Sahl H-G, Pag U, Bonness S, et al.: Mammalian defensins: structures and mechanism of antibiotic activity. J Leukoc Biol 2005, 77:466-475.
12. Bals R, Hiemstra PS: Innate immunity in the lung; how epithelial cells fight against respiratory pathogens. Eur Respir J 2004, 23:327-333.
13. Aarbiou J, Rabe KF, Hiemstra PS: Role of defensins in inflammatory lung disease. Ann Med 2002, 34:96-101.
14. Yang D, Biragyn A, Hoover DM, et al.: Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 2004, 22:181-215.
15. Selsted ME, Ouellette AJ: Mammalian defensins in the antimicrobial immune response. Nat Immunol 2005, 6:551-557.
16. Kao C-Y, Chen Y, Thai P, et al.: IL-17 markedly upregulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kB signaling pathways. J Immunol 2004, 173:3482-3491.
17. Molet S, Hamid Q, Davoine F, et al.: IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001, 108:430-438.
18. Hellings PW, Kasran A, Liu Z, et al.: Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 2003, 28:42-50.
19. Lindén A, Laan M, Anderson GP: Neutrophils, interleukin-17A and lung disease. Eur Respir J 2005, 25:159-172.
20. Proud D, Sanders SP, Wiehler S: Human rhinovirus infection induces airway epithelial cell production of human beta-defensin-2 both in vitro and in vivo. J Immunol 2004, 172:4637-4645.
21. Duits LA, Nibbering PH, van Strijen E, et al.: Rhinovirus increases human beta-defensin-2 and -3 mRNA expression in cultured human bronchial epithelial cells. FEMS Immunol Med Microbiol 2003, 38:59-64.
22. Pizzichini MMM, Pizzichini E, Efthimiadis A, et al.: Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am J Respir Crit Care Med 1998, 158:1178-1184.
23. Jarjour NN, Gern JE, Kelly EAB, et al.: The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol 2000, 105:1169-1177.
24. Wark PAB, Johnston SL, Moric I, et al.: Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002, 19:68-75.
25. Daher KA, Selsted ME, Lehrer RI: Direct inactivation of viruses by human granulocyte defensins. J Virol 1986, 60:1068-1070.
26. Zhang L, Yu W, He T, et al.: Contribution of human a-defensin 1, 2, and 3 to the anti-HIV activity of CD8 antiviral factor. Science 2002, 298:995-1000.
27. Chang TL, Vargas JJ, Del Portillo AK, et al.: Dual role of alpha-defensin-I in anti-HIV-1 innate immunity. J Clin Invest 2005, 115:765-773.
28. Gropp R, Frye M, Wagner TOF, Bargon J: Epithelial defensins impair adenoviral infection: implication for adenovirus-mediated gene therapy. Hum Gene Ther 1999, 10:957-964.
29. Leikina E, Delanoe-Ayari H, Melikov K, et al.: Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nature Immunol 2005, 6:995-1001.
30. Niyonsaba F, Iwabuchi K, Matsuda H, et al.: Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through pertussis toxin-sensitive and phospholipase C-dependent pathway. Int Immunol 2002, 14:421-426.
31. Garcia JR, Jaumann F, Schulz S, et al.: Identification of a novel, multifunctional beta-defensin (human beta-defensin-3) with specific antimicrobial activity: its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res 2001, 306:257-264.
32. Sakamoto N, Mukae H, Fujii T, et al.: Differential effects of alpha- and beta-defensin on cytokine production by cultured human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2005, 288:L508-L513.
33. van Wetering S, Tjabringa CS, Hiemstra PS: Interactions between neutrophil-derived antimicrobial peptides and airway epithelial cells. J Leukoc Biol 2005, 77:444-450.
34. Chaly YV, Paleolog EM, Kolesnikova TS, et al.: Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells. Eur Cytokine Netw 2000, 11:257-266.
35. McWilliam AS, Napoli S, Marsh AM, et al.: Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J Exp Med 1996, 184:2429-2432.
36. Yang D, Chen Q, Chertov O, Oppenheim JJ: Human neutrophil defensins selectively chemoattract naive T and immatue dendritic cells. J Leukoc Biol 2000, 68:9-14.
37. Biragyn A, Ruffini PA, Leifer CA, et al.: Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002, 298:1025-1029.
38. Schlender J, Hornung V, Finke S, et al.: Inhibition of Toll-like receptor 7- and 9- mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J Virol 2005, 79:5507-5515.
39. Kirchberger S, Majdic O, Steinberger P, et al.: Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression. J Immunol 2005, 175:1145-1152.
40. Brogden KA, Heidari M, Sacco RE, et al.: Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease. Oral Microbiol Immunol 2003, 18:95-99.
41. Biragyn A, Belyakov IM, Chow Y-H, et al.: DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses. Blood 2002, 100:1153-1159.
42. Biragyn A, Surenhu M, Yang D, et al.: Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J Immunol 2001, 167:6644-6653.
43. Zhang K, Lu Q, Zhang Q, Hu X: Regulation of activities of NK cells and CD4 expression in T cells by human HNP-1, -2, and -3. Biochem Biophys Res Commun 2004, 323:437-444.
44. Holgate ST, Davies DE, Lackie PM, et al.: Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000, 105:193-204.
45. Aarbiou J, Ertmann M, van Wetering S, et al.: Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol 2002, 72:167-174.
46. McDermott AM, Redfern RL, Zhang B: Human beta-defensin 2 is up-regulated during re-epithelialization of the cornea. Curr Eye Res 2001, 22:64-67.
47. Aarbiou J, Verhoosel RM, van Wetering S, et al.: Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am J Respir Cell Mol Biol 2004, 30:193-201.
48. van Wetering S, van der Linden AC, van Sterkenburg MA, et al.: Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am J Physiol Lung Cell Mol Physiol 2000, 278:L51-L58.
49. Ashcroft GS, Lei K, Jin W, et al.: Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 2000, 6:1147-1153.
50. Varoga D, Pufe T, Harder J, et al.: Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors. Arthritis Rheum 2005, 52:1736-1745.